Common use of Supply of the Compounds Clause in Contracts

Supply of the Compounds. Advaxis and Merck will each use commercially reasonable efforts to supply, or cause to be supplied, the quantities of its respective Compound as are set forth on Appendix C, on the timelines set forth in Appendix C, in each case, for use in the Collaboration Program. In the event that the Party conducting the Collaboration Program determines that the quantities of Compounds set forth on Appendix C are not sufficient to complete the Study, such Party shall so notify the other Party, and the Parties shall discuss in good faith regarding additional quantities of Compounds to be provided and the schedule on which such additional quantities shall be provided. Each Party shall also provide to the other Party a contact person for the supply of its Compound under this Agreement. Notwithstanding the foregoing, or anything to the contrary herein, in the event that either Party is not supplying its Compound in accordance with the terms of this Agreement, or is allocating under Section 8.10, then the other Party shall have no obligation to supply its Compound, or may allocate proportionally.

Supply of the Compounds. Advaxis Syndax and Merck the Alliance will each use commercially reasonable efforts to supply, or cause to be supplied, the quantities of its respective Compound as are set forth on Appendix C, B on the timelines set forth in Appendix CB, in each case, for use in the Collaboration ProgramStudy. In the event that the Party conducting the Collaboration Program Syndax determines that the quantities of Compounds set forth on Appendix C B are not sufficient to complete the StudyStudy (due, such Party for example, to the addition of Study sites or countries), Syndax shall so notify the other PartyAlliance, and the Parties shall discuss in good faith regarding additional quantities of Compounds to be provided and the schedule on which such additional quantities shall may be provided. Each Party shall also provide to the other Party a contact person for the supply of its Compound under this Agreement. Notwithstanding the foregoing, or anything to the contrary herein, in the event that either Party is not supplying its Compound in accordance with the terms of this Agreement, or is allocating under Section 8.10, then the other Party shall have no obligation to supply its Compound, or may allocate proportionally.

Supply of the Compounds. Advaxis Checkmate, the Alliance and Merck will Pfizer shall each use commercially reasonable efforts to supply, or cause to be supplied, the quantities of its respective Compound as are set forth on Appendix C, B on the timelines set forth in Appendix CB, in each case, for use in the Collaboration ProgramStudy. In the event that the Party conducting the Collaboration Program Pfizer determines that the quantities of Compounds set forth on Appendix C B are not sufficient to complete the StudyStudy (due, such Party for example, to the addition of Study sites or countries), Pfizer shall so notify the other PartyAlliance and Checkmate, and the Parties shall discuss in good faith regarding additional quantities of Compounds to be provided and the schedule on which such additional quantities shall may be provided. Each Party shall also provide to the other Party a contact person for the supply of its Compound under this Agreement. Notwithstanding the foregoing, or anything to the contrary herein, in the event that either Party is not supplying its Compound in accordance with the terms of this Agreement, or is allocating under Section 8.10, then the other Party shall have no obligation to supply its Compound, or may allocate proportionally.

Supply of the Compounds. Advaxis Vaximm and Merck the Alliance will each use commercially reasonable efforts to supply, or cause to be supplied, the quantities of its respective Compound as are set forth on Appendix C, B on the timelines set forth in Appendix CB, in each case, for use in the Collaboration ProgramStudy. In the event that the Party conducting the Collaboration Program Vaximm determines that the quantities of Compounds set forth on Appendix C B are not sufficient to complete the StudyStudy (due, such Party for example, to the addition of Study sites or countries), Vaximm shall so notify the other PartyAlliance, and the Parties shall discuss in good faith regarding additional quantities of Compounds to be provided and the schedule on which such additional quantities shall may be provided. Each Party shall also provide to the other Party a contact person for the supply of its Compound under this Agreement. Notwithstanding the foregoing, or anything to the contrary herein, in the event that either Party is not supplying its Compound in accordance with the terms of this Agreement, or is allocating under Section 8.10, then the other Party shall have no obligation to supply its Compound, or may allocate proportionally.

Supply of the Compounds. Incyte and Advaxis and Merck will each use commercially reasonable efforts to supply, or cause to be supplied, the quantities of its respective Compound as are set forth on in Appendix CD, on the timelines set forth in Appendix CD, in each case, for use in the Collaboration ProgramStudy. In the event that the Party conducting the Collaboration Program Study determines that the quantities of Compounds set forth on Appendix C D are not sufficient to complete the Study, such Party shall so notify the other Party, and the Parties shall discuss in good faith regarding additional quantities of Compounds to be provided and the schedule on which such additional quantities shall be provided. Each Party shall also provide to the other Party a contact person for the supply of its Compound under this Agreement. Notwithstanding the foregoing, or anything to the contrary herein, in the event that either Party is not supplying its Compound in accordance with the terms of this Agreement, or is allocating under Section 8.10, then the other Party shall have no obligation to supply its Compound, or may allocate proportionally.